ACRAL LENTIGINOUS MELANOMA STAGE III

ACRAL LENTIGINOUS MELANOMA STAGE III was reported 5 times

ACRAL LENTIGINOUS MELANOMA STAGE III is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Orexin Receptor Antagonist [EPC] 1 0.0001
1 Phosphodiesterase 5 Inhibitor [EPC] 2 0.0000
2 Xanthine Oxidase Inhibitor [EPC] 2 0.0000
3 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
4 Opioid Agonist [EPC] 2 0.0000
5 Dihydropyridine Calcium Channel Blocker [EPC] 2 0.0000
6 Vitamin C [EPC] 1 0.0000
7 Proton Pump Inhibitor [EPC] 1 0.0000
8 Tumor Necrosis Factor Blocker [EPC] 1 0.0000